13.30USD-2.81%Mkt Cap: 1.10B USDP/E: —Last update: 2026-06-01
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.10B USD
Enterprise Value1.26B USD
Revenue (TTM)7.61M USD
Gross Profit29.30M USD
Net Income (TTM)-231.96M USD
Revenue/Share0.0980 USD
Last Price13.30 USD
Fiscal Year EndDec 2025
MR QuarterDec 2018
Employees214
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS30233G2093
Valuation
P/E (Trailing)—
P/E (Forward)-4.74
PEG—
EV/EBITDA-4.52
EV/Revenue165.71
P/S149.54
P/B34.29
EPS (TTM)-3.51
EPS (Forward)-2.87
52W Range
6.86053% of range19.11
52W High19.11 USD
52W Low6.860 USD
Profitability
Gross Margin93.41%
Oper. Margin-450.65%
EBITDA Margin0.00%
Profit Margin-739.42%
ROE-75.78%
ROA-63.73%
Growth
Revenue Growth161.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-240.11M USD
CapEx (TTM)3.28M USD
FCF Margin-2215.98%
FCF Yield-15.30%
Net Debt-27.64M USD
Net Debt/EBITDA0.10
Balance Sheet
Debt/Equity0.07
Current Ratio6.66
Quick Ratio5.97
Book Value/Sh0.3960 USD
Cash/Share0.4770 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 9, 2020
Splits
Last Split1:10
Split DateDec 9, 2020
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)37.00 USD
Target Range20.00 USD – 68.00 USD
# Analysts12
Ownership
Shares Out.83.84M
Float75.28M
Insiders3.68%
Institutions110.05%
Short Interest
Short Ratio16.7d
Short % Float17.79%
Short % Out.16.88%
Shares Short14.15M
Short (prev mo.)13.66M
Technical
SMA 5013.44 (-1.1%)
SMA 20014.02 (-5.1%)
Beta1.77
S&P 52W Chg27.94%
Avg Vol (30d)845.62K
Avg Vol (10d)912.69K
Technical Indicators
RSI (14)55.1
MACD-0.1502
MACD Signal-0.2639
MACD Hist.+0.1137
BB Upper14.43 USD
BB Middle13.15 USD
BB Lower11.88 USD
BB Width19.38%
ATR (14)0.7621 USD
Vol Ratio (20d)0.61x